Depression as an evolutionary adaptation: Anatomical organisation around the third ventricle

Medical Hypotheses

Volumn 74, Issue 4, 2010, Pages 735-740

  Hendrie, C A ^a   Pickles, A R ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN; SEROTONIN;

AMYGDALOID NUCLEUS; ANOREXIA; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR CHANGE; BRAIN FUNCTION; BRAIN REGION; BRAIN THIRD VENTRICLE; CIRCADIAN RHYTHM; COGNITIVE DEFECT; DEPRESSION; DISEASE SEVERITY; EVOLUTIONARY ADAPTATION; FEAR; HUMAN; HYPOTHALAMUS; LETHARGY; MAMMILLARY BODY; MEMORY DISORDER; MONOAMINERGIC SYSTEM; NEUROANATOMY; NEUROTRANSMITTER RELEASE; PINEAL BODY; PSYCHOSOCIAL WITHDRAWAL; PUBLICATION; SEXUAL DYSFUNCTION; SLEEP DISORDER; STRIA TERMINALIS; THALAMUS;

ANTIDEPRESSIVE AGENTS; BRAIN; COMMUNICATION; DEPRESSION; DEPRESSIVE DISORDER; EVOLUTION; HUMANS; POPULATION GROUPS; SOCIAL BEHAVIOR; SOCIAL ENVIRONMENT; THIRD VENTRICLE;

EID: 77649338497     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.10.026     Document Type: Article

References (75)

1. Altar C.A. Neurotrophins and depression. Trends Pharmacol Sci 20 (1999) 59-62
2. Angst J. The epidemiology of depressive disorders. Eur Neuropsychopharmacol 5 (1995) 95-98
3. Aggleton J.P. The amygdala: a functional analysis (2000), Oxford University Press, Oxford
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
5. Arborelius L., Owens M.J., Plotsky P.M., and Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 160 (1999) 1-12
6. Baumann B., Bornschlegl C., Krell D., and Bogerts B. Changes in CSF spaces differ in endogenous and neurotic depression A planimetric CT scan study. J Affect Dis 45 (1997) 179-188
7. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatr 4 (1961) 561-571
8. Bernstein H.G., Krause S., Klix M., Steiner J., Dobrowolny H., and Bogerts B. Structural changes of mammillary bodies are different in schizophrenia and bipolar disorder. Schizophr Res 98 (2008) 7-8
9. Blazer D.G. Mood disorders: epidemiology. In: Sadock B.J., and Sadock V.A. (Eds). Comprehensive textbook of psychiatry (2000), Lippincott, Williams and Wilkins, New York 1298-1308
10. Bloch R.G., Dooneief A.S., Buchberg A.S., and Spellman S. The clinical effects of isoniazid and iproniazid in the treatment of pulmonary tuberculosis. Ann Intern Med 40 (1954) 881-900
11. Blumer A., EhrenFeucht A., Hauseler D., and WSarmuth M.K. Occam's razor information. Proc Lett 24 (1987) 377-388
12. Brodie B.B., and Shore P.A. A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Ann NY Acad Sci 66 (1957) 631-642
13. Brown S.L., Steinberg R.L., and van Praag H.M. The pathogenesis of depression: reconsideration of neurotransmitter data. In: den Boer J.A., and Sitsen J.M.A. (Eds). Handbook of depression and anxiety: a biological approach (1994), Marcel Dekker, New York 317-347
14. Bunney W.E., and Davis L.M. Norepinephrine in depressive reactions. Arch Gen Psychiatr 13 (1965) 483-494
15. Burt V.K., and Stein K. Epidemiology of depression throughout the female life cycle. J Clin Psychiatry 63 Suppl 7 (2002) 9-15
16. Buss D.M. Sex differences in human mate preferences: evolutionary hypotheses testing in 37 cultures. Behav Brain Sci 12 (1989) 1-49
17. Carlsson A. Brain monoamines and psychotropic drugs. Neuropsychopharmacology 2 (1961) 417
18. Cocchi M., Tonello L., and Lercker G. Platelet Stearic Acid in different population groups: biochemical and functional hypothesis. Nutr Clín Diet Hosp 29 (2009) 34-45
19. Connor T.J., and Leonard B.E. Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci 62 (1998) 583-606
20. Dixon A.K., and Fisch H.U. Animal models and ethological strategies for early drug-testing in humans. Neurosci Biobehav Rev 23 2 (1998) 345-358
21. Dasari M., Friedman L., Jesberger J., Stuve T.A., Findling F.L., Swales T.P., et al. A magnetic resonance imaging study of thalamic area in adolescent patients with either schizophrenia or bipolar disorder as compared to healthy controls. Psychiatr Res 91 (1999) 155-162
22. Dupont R.M., Jernigan T.L., Heindel W., Butters N., Shafer K., Wilson T., et al. Magnetic resonance imaging and mood disorders: localization of white matter and other subcortical abnormalities. Arch Gen Psychiatr 52 (1995) 747-755
23. Dwivedi Y. Brain-derived neurotrophic factor: role in depression and suicide. Neuropsychiatr Dis Treat 5 (2009) 433-449
24. Emlen S.T., and Oring L.W. Ecology, sexual selection and the evolution of mating systems. Science 197 (1977) 215-223
25. Farber J.L. The role of calcium ions in toxic cell injury. Environ Health Perspect 84 (1990) 107-111
26. Falcón J., Besseau L., Fuentès M., Sauzet S., Magnanou E., and Boeuf G. Structural and functional evolution of the pineal melatonin system in vertebrates. Trends Comp Endocrinol Neurobiol 1163 (2009) 101-111
27. Fossi L., Faravlli C., and Paoli M. The ethological approach to assessment of depressive disorders. J Nerv Ment Dis 172 (1984) 332-340
28. Gilbert P., and Allan S. The role of defeat and entrapment (arrested flight) in depression: an exploration of an evolutionary view. Psychol Med 28 (1998) 585-598
29. Gray J.A., and McNaughton N. Comparison between the behavioural effects of septal and hippocampal lesions: a review. Neurosci Biobehav Rev 7 (1983) 119-188
30. Hastings R.S., Parsey R.V., Oquendo M.A., Arango V., and Mann J. Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression. Neuropsychopharmacology 29 (2004) 952-959
31. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiat 23 (1960) 56-62
32. Hendrie C.A., Sarailly J., and Starkey N. Evidence to suggest that self-medication with alcohol is not an effective treatment for the control of depression. J Psychopharm 12 (1998) 112
33. Hendrie C.A., Pickles A.R., Duxon M.S., Riley G.J., and Hagan J.J. Effects of fluoxetine on social behaviour and plasma corticosteroid levels in female Mongolian gerbils. Behav Pharm 14 7 (2003) 545-550
34. Hendrie C.A., and Pickles A.R. Depression as an evolutionary adaptation: implications for the development of preclinical models. Med Hypoth 72 (2009) 342-347
35. Hendrie CA. The funding crisis in psychopharmacology: an historical perspective. J Psychopharm 2010; 24(3), in press.
36. Heninger G., Delgado P., and Charney D. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry 29 (1996) 2-11
37. Hughes S., and Cohen D. A systematic review of long-term studies of drug treated and non-drug treated depression. J Affect Dis 118 (2009) 9-18
38. Jick H., Kaye J.A., and Jick S.S. Antidepressants and the risk of suicidal behaviours. JAMA 292 (2004) 338-343
39. Keller M.B. Depression: a Long Term Illness. Br J Psychiatry 165 s26 (1994) 9-15
40. Kessler R.C., Berglund P., Demler O., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289 (2003) 3095-3105
41. Kramer M.S., Cutler N., Feighner J., Ram S., et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281 (1998) 1640-1645
42. Kreicbergs U., Valdimarsdóttir U., Onelöv E., Henter J.I., and Steineck G. Anxiety and depression in parents 4-9 years after the loss of a child owing to a malignancy: a population-based follow-up. Psychol Med 34 (2004) 1431-1441
43. Kumar R., Woo M.A., Birrer B.V.X., Macey P.M., Fonarow G.C., Hamilton M.A., and Harper R.M. Mammillary bodies and fornix fibers are injured in heart failure. Neurobiol Dis 33 (2009) 236-242
44. Lacasse J.R., and Leo J. Serotonin and depression: a disconnect between the advertisements and the scientific literature. PLoS Med 2 12 (2005) e392
45. Lecourtier L., and Kelly P.H. A conductor hidden in the orchestra? Role of the habenular complex in monoamine transmission and cognition. Neurosci Biobehav Rev 31 (2007) 658-672
46. Maas J.W. Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. Arch Gen Psychiatr 32 (1975) 1357-1361
47. Middlemiss D.N., Price G.W., and Watson J.M. Serotonergic targets in depression. Curr Opin Pharmacol 2 (2002) 18-22
48. Möller H.J., and Volz H.P. Drug treatment of depression in the 1990s. An overview of achievements and future possibilities. Drugs 52 (1996) 625-638
49. Moncrieff J. Are antidepressants as effective as claimed? No, they are not effective at all. Can J Psychiatry 52 (2007) 96-97
50. Nemeroff C.B. The corticotrophin releasing factor hypothesis of depression: new findings and new directions. Mol Psychiatry 1 (1996) 336-342
51. Neylan T.C. Treatment of sleep disturbances in depressed patients. J Clin Psychiatry 56 (1995) 56-61
52. NICE. Depression: management of depression in primary and secondary care. Clinical Guideline 23. London: National Institute for Clinical Excellence; 2004.
53. Perea G., Navarrete M., and Araque A. Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci 32 (2009) 421-431
54. Pickles A.R., Hendrie C.A., Hagan J.J., and Jones D.N.C. Behavioural consequences of moving house in Mongolian gerbils: do antidepressants help?. J Psychopharm 18 (2004) A17
55. Price J., Sloman L., Gardner R., Gilbert P., and Rohde P. The social competition hypothesis of depression. Br J Psychiatry 164 (1998) 309-315
56. Reul J.M.H.M., and Holsboer F. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharmacol 2 (2002) 23-33
57. Saksida L.M., Galea A.M., and Kavaliers M. Predator-induced opioid and non-opioid mediated analgesia in young meadow voles: sex differences and developmental changes. Brain Res 617 (1993) 214-219
58. Schelde J.T.M. Major depression: behavioral markers of depression and recovery. J Nerv Ment Dis 186 (1998) 133-140
59. Schildkraut J.J. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122 (1965) 609-622
60. Sheline Y.I., Gado M.H., and Price J.L. Amygdala core nuclei volumes are decreased in recurrent major depression. Brain Imag 9 (1998) 2023-2028
61. Sheline Y.I., Sanghavi M., Mintun M.A., and Gado M. Depression duration but not age predicts hippocampal volume loss in women with recurrent major depression. J Neurosci 19 (1999) 5034-5043
62. Sheline Y.I., Gado M.H., and Kraemer H.C. Untreated depression and hippocampal volume loss. Am J Psychiatry 160 (2003) 1516-1518
63. Sloman L, Gilbert P. Subordination and defeat. Lawrence Erlbaum; 2000.
64. Stahl S.M. Essential psychopharmacology: neuroscientific basis and practical applications (2000), Cambridge University Press, Cambridge
65. Stockmeier C.A., Mahajan G., Konick L.C., Overholser J.C., Jurjus G.J., Meltzer H.Y., et al. Cellular changes in the postmortem hippocampus in major depression. Biol Psychiatry 56 (2004) 640-650
66. Strickland P.L., Deakin J.F.W., Percival C., Dixon J., Gater R.A., and Goldberg D.P. Biosocial origins of depression in the community: Interactions between social adversity, cortisol and serotonin transmission. Br J Psychiatry 180 (2002) 168-173
67. Tsivilis D., Vann S.D., Denby C., Roberts N., Mayes A.R., Montaldi D., et al. A disproportionate role for the fornix and mammillary bodies in recall versus recognition memory. Nat Neurosci 11 (2008) 834-842
68. Usall J., Pinto-Meza A., Fernández A., de Graaf R., Demyttenaere K., Alonso J., et al. Suicide ideation across reproductive life cycle of women results from a European epidemiological study. J Affect Dis 116 (2009) 144-147
69. van Kampen M., Kramer M., Hiemke C., Flügge G., and Fuchs E. The chronic psychosocial stress paradigm in male tree shrews: evaluation of a novel animal model for depressive disorders. Stress 5 (2002) 37-46
70. Vermeiren C., Najimi M., Vanhoutte N., Tilleux S., de Hemptinne I., Maloteaux J.M., et al. Acute up-regulation of glutamate uptake mediated by mGluR5a in reactive astrocytes. J Neurochem 94 (2005) 405-416
71. Weissman M.M., Bland R.C., Caninio G.F., Faravelli C., Greenwald S., Hwu H.G., et al. Cross-national epidemiology of major depression and bipolar disorder. J Am Med Assoc 276 4 (1996) 293-299
72. Wittchen H.U., Knauper B., and Kessler R.C. Lifetime risk of depression. Br J Psychiatry 165 (1994) 16-22
73. World Health Organization. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. Geneva: Geneva: WHO; 1993.
74. World Health Organization. The world health report 2002: reducing risks, promoting healthy life. Geneva, Switzerland: WHO; 2002.
75. Zisook S., and Shuchter S.R. Depression through the first year after the death of a spouse. Am J Psychiatry 148 (1991) 1346-1352